Latest Dilution News

VHM Limited has secured A$5 million through a fully underwritten placement priced at A$0.26 per share, funding critical early engineering and procurement ahead of a mid-2026 final investment decision for its Goschen Rare Earth and Mineral Sands Project.

Red Sky Energy is raising approximately AUD 4.2 million through a fully underwritten non-renounceable rights issue priced at 0.1 cents per share. The capital will fund participation in Santos-operated wells and support ongoing operations.

Sunrise Energy Metals has confirmed strong economics for its Syerston Scandium Project with a US$120 million feasibility study, targeting 60 tonnes per year of scandium oxide and potential expansion to 180 tonnes. The project benefits from US government financing interest and rising global demand amid Chinese export restrictions.

Tartana Minerals has closed a $275,000 share placement to its directors at a significant premium, issuing 5.5 million shares and promising options exercisable at 5.5 cents. The company also flagged imminent settlement of a larger $1.7 million placement from earlier this year.

Emerald Resources NL reports robust high-grade gold intercepts from its Dingo Range project in Western Australia and key Cambodian assets, reinforcing resource growth and underground development potential.

Eagle Mountain Mining has formalised a joint venture with Nittetsu Mining for the Oracle Ridge copper project in Arizona, with Nittetsu committing US$20 million to advance exploration and development while managing the operation.

Rox Resources reports strong underground progress and high-grade gold intercepts at Youanmi, reinforcing confidence in hitting production targets on schedule.

KMD Brands has secured NZ$11 million from its retail entitlement offer, with a 52% participation rate. The company now moves to clear a 169 million share shortfall through a retail bookbuild, while shares remain halted ahead of trading resumption.

Lumos Diagnostics has secured a key FDA 510(k) clearance with CLIA waiver for its FebriDx rapid test, unlocking a US$1 billion-plus market opportunity and triggering milestone payments exceeding US$6 million. The company reported a 37% revenue jump in Q3 FY26, supported by a A$20 million placement and ongoing clinical and development projects.

MyEco Group has locked in $0.92 million through its Series 2 convertible note program, reinforcing its growth trajectory with funding earmarked for a new GRS-certified recycled bin liner range. The raise supplements a solid cash position while aiming to limit shareholder dilution amid challenging market conditions.

Patrys has raised A$3.2 million through a share placement to fund its injectable quetiapine program’s Phase 1A clinical trial and FDA pre-IND preparations.

Neometals has secured A$7.9 million through a placement and launched a concurrent A$5.1 million entitlement offer to fund gold production at Barrambie and advance lithium exploration in Utah. The capital raise supports a near-term production joint venture and aggressive resource expansion.